Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Completed

• Conditions: Brain Tumor

• Registration Number: NCT03090386
• Lead Sponsor: Mayo Clinic

Brief Summary

This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-25
• Study First Submitted: 2017-03-10
• Study First Submitted QC: 2017-03-23
• Study First Posted: 2017-03-24
• Primary Completion: 2018-11-15
• Status Verified: 2020-11
• Study Completion: 2020-11-15
• Last Update Submitted: 2020-11-30
• Last Update Posted: 2020-12-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• be between18 to 89 years old;
• have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery)
• have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study;
• be native speakers of American English;
• have obtained a minimum of a high school education;
• self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and
• must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion Criteria

• are younger than 18 years old or older than 89 years old;
• have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery)
• have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment;
• are not native speakers of American English;
• have not obtained a minimum of a high school education;
• do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or
• do not demonstrate the capacity to sign informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cognitive Communication Survey	1 day at time of consent	Survey is completed at time of consent

Secondary Outcome Measures

Name	Time	Method
Cognitive-linguistic Standardized Testing	within 3 months of cognitive communication survey	Standardized testing will be completed
Follow-up Survey	within 6 months after completion of standardized testing	Survey will be completed

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States